Share '[Upcoming Webinar] Akashi Provides Update on HT-100'
Monday, March 27 at 1:30 PM EST
Please join Parent Project Muscular Dystrophy and Akashi Therapeutics as we host a webinar Monday, March 27 at 1:30 PM ET to discuss HT-100 and next steps for the clinical program.
Akashi CEO Marc Blaustein will present data from the previous clinical program of HT-100 and discuss FDA’s recent decision to allow the clinical development of HT-100 to resume, and le…
You can share this event in two ways…
Share this link:
Send it with your computer's email program: Email this